Al Kury LT, Abdoh A, Ikbariah K, Sadek B, Mahgoub M (2021) In vitro and in vivo antidiabetic potential of monoterpenoids: an update. Molecules 27(1):182. https://doi.org/10.3390/molecules27010182
Article CAS PubMed PubMed Central Google Scholar
Ali A et al (2022) Plants with therapeutic potential for ischemic acute kidney injury: a systematic review. Evid-Based Complement Alternat Med 2022:1–22. https://doi.org/10.1155/2022/6807700
Al-Qahtani M et al (2024) The awareness, prevalence, and risk factors of chronic kidney disease among diabetes mellitus and hypertensive patients in the Aseer region, Saudi Arabia. Cureus 16(2):e53366. https://doi.org/10.7759/cureus.53366
Article PubMed PubMed Central Google Scholar
Amorim RG, da Silva Guedes G, de Lima Vasconcelos SM, de Farias Santos JC (2019) Kidney disease in diabetes mellitus: cross-linking between hyperglycemia, redox imbalance and inflammation. Arq Bras Cardiol 112(5):577–587. https://doi.org/10.5935/abc.20190077
Article CAS PubMed PubMed Central Google Scholar
Anders H-J, Saxena R, Zhao M, Parodis I, Salmon JE, Mohan C (2020) Lupus nephritis. Nat Rev Dis Primers 6(1):7. https://doi.org/10.1038/s41572-019-0141-9
Aqil M, Ahad A, Sultana Y, Ali A (2007) Status of terpenes as skin penetration enhancers. Drug Discov Today 12(23–24):1061–1067. https://doi.org/10.1016/j.drudis.2007.09.001
Article CAS PubMed Google Scholar
Ardiansyah A et al (2012) Lupeol supplementation improves blood pressure and lipid metabolism parameters in stroke-prone spontaneously hypertensive rats. Biosci Biotechnol Biochem 76(1):183–185. https://doi.org/10.1271/bbb.110559
Article CAS PubMed Google Scholar
Avila-Carrasco L, García-Mayorga EA, Díaz-Avila DL, Garza-Veloz I, Martinez-Fierro ML, González-Mateo GT (2021) Potential therapeutic effects of natural plant compounds in kidney disease. Molecules 26(20):6096. https://doi.org/10.3390/molecules26206096
Article CAS PubMed PubMed Central Google Scholar
Babaeenezhad E et al (2021) D-limonene alleviates acute kidney injury following gentamicin administration in rats: role of NF-κB Pathway, mitochondrial apoptosis, oxidative stress, and PCNA. Oxid Med Cell Longev 2021:1–16. https://doi.org/10.1155/2021/6670007
Bagavant H, Fu SM (2009) Pathogenesis of kidney disease in systemic lupus erythematosus. Curr Opin Rheumatol 21(5):489–494. https://doi.org/10.1097/BOR.0b013e32832efff1
Article CAS PubMed PubMed Central Google Scholar
Baharvand-Ahmadi B, Asadi-Samani M (2017) A mini-review on the most important effective medicinal plants to treat hypertension in ethnobotanical evidence of Iran. J Nephropharmacol 6(1):3–8
Barri YM (2008) Hypertension and kidney disease: a deadly connection. Curr Hypertens Rep 10(1):39–45. https://doi.org/10.1007/s11906-008-0009-y
Bnouham M, Merhfour FZ, Ziyyat A, Aziz M, Legssyer A, Mekhfi H (2010) Antidiabetic effect of some medicinal plants of Oriental Morocco in neonatal non-insulin-dependent diabetes mellitus rats. Hum Exp Toxicol 29(10):865–871. https://doi.org/10.1177/0960327110362704
Brunetti C, Di Ferdinando M, Fini A, Pollastri S, Tattini M (2013) Flavonoids as antioxidants and developmental regulators: relative significance in plants and humans. Int J Mol Sci 14(2):3540–3555. https://doi.org/10.3390/ijms14023540
Article CAS PubMed PubMed Central Google Scholar
Camargo SB et al (2018) Antihypertensive potential of linalool and linalool complexed with β-cyclodextrin: effects of subchronic treatment on blood pressure and vascular reactivity. Biochem Pharmacol 151:38–46. https://doi.org/10.1016/j.bcp.2018.02.014
Article CAS PubMed Google Scholar
Cao Z, Cooper ME (2011) Pathogenesis of diabetic nephropathy. J Diabetes Investig 2(4):243–247. https://doi.org/10.1111/j.2040-1124.2011.00131.x
Article CAS PubMed PubMed Central Google Scholar
Cao Y-L, Lin J-H, Hammes H-P, Zhang C (2022) Flavonoids in treatment of chronic kidney disease. Molecules 27(7):2365. https://doi.org/10.3390/molecules27072365
Article CAS PubMed PubMed Central Google Scholar
Chappell J, Coates RM (2010) Sesquiterpenes. In: Comprehensive natural products II. Elsevier, pp 609–641. https://doi.org/10.1016/B978-008045382-8.00005-8
Chawla LS, Eggers PW, Star RA, Kimmel PL (2014) Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med 371(1):58–66. https://doi.org/10.1056/NEJMra1214243
Article CAS PubMed PubMed Central Google Scholar
Chen C-M, Juan S-H, Chou H-C (2018) Hyperglycemia activates the renin-angiotensin system and induces epithelial-mesenchymal transition in streptozotocin-induced diabetic kidneys. J Renin Angiotensin Aldosterone Syst 19(3):1470320318803009. https://doi.org/10.1177/1470320318803009
Article CAS PubMed PubMed Central Google Scholar
Chen TK, Knicely DH, Grams ME (2019) Chronic kidney disease diagnosis and management: a review. JAMA 322(13):1294–1304. https://doi.org/10.1001/jama.2019.14745
Article CAS PubMed PubMed Central Google Scholar
Chiocchio I, Mandrone M, Tomasi P, Marincich L, Poli F (2021) Plant secondary metabolites: an opportunity for circular economy. Molecules 26(2):495. https://doi.org/10.3390/molecules26020495
Article CAS PubMed PubMed Central Google Scholar
Chou Y-H, Huang T-M, Chu T-S (2017) Novel insights into acute kidney injury–chronic kidney disease continuum and the role of renin–angiotensin system. J Formos Med Assoc 116(9):652–659. https://doi.org/10.1016/j.jfma.2017.04.026
Article CAS PubMed Google Scholar
Cox-Georgian D, Ramadoss N, Dona C, Basu C (2019) Therapeutic and medicinal uses of terpenes. In: Medicinal plants. Springer International Publishing, pp 333–359. https://doi.org/10.1007/978-3-030-31269-5_15
de Boer IH et al (2022) Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Diabetes Care 45(12):3075–3090. https://doi.org/10.2337/dci22-0027
Article CAS PubMed PubMed Central Google Scholar
Del Prado-Audelo ML et al (2021) Therapeutic applications of terpenes on inflammatory diseases. Front Pharmacol 12:704197. https://doi.org/10.3389/fphar.2021.704197
Article CAS PubMed PubMed Central Google Scholar
Dendup T, Feng X, Clingan S, Astell-Burt T (2018) Environmental risk factors for developing type 2 diabetes mellitus: a systematic review. Int J Environ Res Public Health 15(1):78. https://doi.org/10.3390/ijerph15010078
Article PubMed PubMed Central Google Scholar
Dias CJ et al (2022) Carvacrol reduces blood pressure, arterial responsiveness and increases expression of MAS receptors in spontaneously hypertensive rats. Eur J Pharmacol 917:174717. https://doi.org/10.1016/j.ejphar.2021.174717
Article CAS PubMed Google Scholar
Du Q et al (2021) Loganin alleviates macrophage infiltration and activation by inhibiting the MCP-1/CCR2 axis in diabetic nephropathy. Life Sci 272:118808. https://doi.org/10.1016/j.lfs.2020.118808
Article CAS PubMed Google Scholar
Evidente A et al (2015) Sesterterpenoids with anticancer activity. Curr Med Chem 22(30):3502–3522. https://doi.org/10.2174/0929867322666150821101047
Article CAS PubMed PubMed Central Google Scholar
Ezhumalai M, Ashokkumar N, Pugalendi KV (2015) RETRACTED: combination of carvacrol and rosiglitazone ameliorates high fat diet induced changes in lipids and inflammatory markers in C57BL/6J mice. Biochimie 110:129–136. https://doi.org/10.1016/j.biochi.2014.12.005
Article CAS PubMed Google Scholar
Farris AB, Colvin RB (2012) Renal interstitial fibrosis. Curr Opin Nephrol Hypertens 21(3):289–300. https://doi.org/10.1097/MNH.0b013e3283521cfa
Article PubMed PubMed Central Google Scholar
Feng H, Zhu X, Tang Y, Fu S, Kong B, Liu X (2021) Astragaloside IV ameliorates diabetic nephropathy in db/db mice by inhibiting NLRP3 inflammasome-mediated inflammation. Int J Mol Med 48(2):164. https://doi.org/10.3892/ijmm.2021.4996
Article CAS PubMed PubMed Central Google Scholar
Ferenbach DA, Bonventre JV (2016) Acute kidney injury and chronic kidney disease: from the laboratory to the clinic. Nephrol Ther 12(Suppl 1):S41-8. https://doi.org/10.1016/j.nephro.2016.02.005
Article PubMed PubMed Central Google Scholar
Fernandes SM, Watanabe M, de Fátima Fernandes Vattimo M (2021) Inflammation: improving understanding to prevent or ameliorate kidney diseases. J Venom Anim Toxins Incl Trop Dis 27:e20200162.
留言 (0)